MacMusic  |  PcMusic  |  440 Software  |  440 Forums  |  440TV  |  Zicos
company
Search

Pro Audio > Industry

Monday April 19, 2021. 03:03 PM
RICOVR Healthcare announced that it has raised $1.5 million in funding to commercialize its point-of-care testing device for THC and COVID-19. Princeton, NJ, April 19, 2021 (GLOBE NEWSWIRE) — RICOVR Healthcare, creator of the XALIVATM rapid diagnostics platform, announced...
    0
LAS VEGAS, NV, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Pharma Inc. (OTC: OWPC), (“OWP” or the “Company”), a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that NBA star,...
    0
Advances Potential for Use of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) as a Safe and Effective Treatment Option On Track to Advance Planned Analyses and Announce Top-Line Data in Plantar Fasciitis, Achilles Tendonitis and Knee Osteoarthritis in Q3 2021...
    0
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety VANCOUVER, British Columbia, April 19, 2021 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”)...
    0
NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Brain Scientific Inc. (OTCQB: BRSF) (the “Company” or “Brain Scientific”), a neurology-focused medical device and software company, filed its Annual Report on Form 10-K for the fiscal year ended Dec....
    0
TurboCAR Technology Allows a Programmable Cytokine Signaling to Potentially Control T Cell Exhaustion and Improve Function and Potency of AlloCAR T Cells Phase 1 IGNITE Trial Expected to Begin in Mid-2021 ALLO-605 is One of Allogene’s Three Strategies to Target BCMA for...
    0
Submission has been made for review under the accelerated approval pathway  LEXINGTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents which includes checkpoint antibodies, cell therapies,...
    0
SHANGHAI, China, April 19, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (“ECMOHO” or the “Company”; Nasdaq: MOHO), a leading integrated solution provider in the non-medical health and wellness market in China, today announced that it has signed a memorandum of understanding...
    0
Dr. Kushwah discussing the Aspen contract along with what it means for Predictmedix Inc. Dr. Kushwah talks about the Aspen deployment with Steve from Proactive Investors. TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)...
    0
PRESS RELEASE April 19, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it has entered into a partnership with the Foundation for Prader-Willi Research (FPWR) to increase awareness within FPWR’s community...
    0
Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive, the homecare management software that increases efficiency, capacity, compliance and communication between managers and...
    0
EVOTEC GRANTS KAZIA THERAPEUTICS AN EXCLUSIVE WORLDWIDE LICENSE FOR DEVELOPMENT AND COMMERCIALISATION OF ONCOLOGY ASSET EVT801 KAZIA INTENDS TO INITIATE A PHASE I CLINICAL TRIAL OF EVT801 MANAGED BY EVOTEC EVOTEC WILL PROVIDE CHEMISTRY, MANUFACTURING AND CONTROLS (“CMC”)...
    0
GENEVA, SWITZERLAND / ACCESSWIRE / April 19, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company“), commented today on certain statements made by NeuroRx, Inc., its collaboration partner for the development of RLF-100TM (aviptadil) pursuant...
    0
Sunday April 18, 2021. 03:03 PM
Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy Effect on coronary plaque stabilization reported to be significant at 9 months and sustained at 18 months DUBLIN, Ireland and BRIDGEWATER, N.J.,...
    0
VANCOUVER, BC / ACCESSWIRE / April 17, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the “Company”) a biotechnology research and development life sciences enterprise focused on advancing psychedelic medicines to market, is pleased to announce it ...
    1
Saturday April 17, 2021. 06:03 PM
 Elucid Software Quantifies Plaque Morphology to Enable Better Assessment of IPE Treatment Effects BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular...
    1
There are certain vein problems that women are more susceptible to, so it’s important to counteract these issues by taking extra steps to protect vein health. There are reasons why females are at an increased risk of problems and there are steps you can take to protect...
    1
Secondary endpoint data for once-nightly FT218 further supports previously announced topline data demonstrating clinically meaningful results at 6 g, 7.5 g, and 9 g doses DUBLIN, Ireland, April 17, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company...
    1
M Banks | How to Cultivate Your Stage Persona: 10 Tips Owen Davie | How to execute a COVID-safe live event Rachelle Wilber | Music photography: The perfect shot Mark Knight | In search of meaningful engagement
    1
JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has appointed Dr. Glynn Wilson as Chief Science Officer, Rich Miller as Chief...
    0
News copyright owned by their original publishers | Copyright © 2004 - 2021 Zicos / 440Network
115 sources
Current Date
Apr, Tue 20 - 10:18 CEST